Rituximab

Product Details:

Reditux 500mg injection, which contains the active ingredient Rituximab, is used to treat various conditions including blood cancers (like non-Hodgkin lymphoma and chronic lymphocytic leukemia) and certain autoimmune disorders such as rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris. It works by targeting specific immune cells (CD20-positive B cells) or interfering with the immune system's processes that cause inflammation and disease progression.
Specific Uses:
Non-Hodgkin Lymphoma (NHL): Reditux is used alone or with other anticancer agents to treat this type of blood cancer.
Chronic Lymphocytic Leukemia (CLL): It is also used for this form of blood cancer.
Rheumatoid Arthritis: It is used for moderate-to-severe rheumatoid arthritis, often in combination with other medications.
Inflammatory Conditions:
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Reditux is used to manage these autoimmune conditions that cause inflammation of blood vessels.
Pemphigus Vulgaris: It treats this autoimmune condition characterized by severe blistering of the skin and mucous membranes.
How it Works:
In Cancers: Rituximab targets CD20-positive B cells, which are involved in the growth and spread of certain blood cancers, thereby inhibiting their growth.
In Autoimmune Diseases: It interferes with the immune system's processes, reducing inflammation in joints or other affected tissues and preventing further damage.
Important Considerations:
Reditux is administered by a qualified healthcare professional in a clinical setting.
Before starting treatment, inform your doctor about any allergies, infections, heart conditions, liver or kidney problems, and all other medications you are taking.
The medicine can affect blood cell counts and increase susceptibility to infections, so regular blood tests may be required.